The Royal Group

We Understand How to Get Over-The-Counter Products to Market

TRG represents an industry-leading single-source solution for prescription to non-prescription (Rx to OTC) switches* and for retail launches for new OTC products that require a true turnkey solution from design through delivery.

TRG makes it easy for clients to plan and deliver programs under a strict umbrella of compliance for Over-the-Counter (OTC) design through fulfillment. Our speed to market is an industry benchmark. Our adherence to our clients’ Standard Operating Procedures (SOPs) and our strict adherence to current Good Manufacturing Practices (GMPs) ensure that your projects have a safe and quick trajectory to be in store, on time.

Clients Who Trust TRG

Looking For a Quote?

Whether you already have a temporary display program ready or are starting from scratch need assistance, we can help.

Market Keys

As the industry-leading provider of multi-branded OTC programs to retailers, TRG has the size and scale to inventory, stage, design, build and deliver multi-branded programs faster and more accurately than other organizations.

Strict GMP’s and SOP’s incorporating CPG-specific guidelines for brands

ISO 9001:2015, FDA registered

Five U.S. locations for OTC fulfillment

Strict mapping and in-out procedures for managing client products

Enterprise-wide ERP software; custom on-line customer portal

ISTA standards and customer-supplied testing standards; in-house ISTA lab

Timelines are not stable or predictable. We know that ‘tweaks’ to a program are inevitable; change and issues occur. Clients require and deserve a flexible, organized partner in this category. That said we are proud to be able to offer our clients industry-leading timelines.

Include EDI, ERP and bar coding

Hand assembly, display assembly, pouching, bagging, shrink wrapping, kitting, inspections, rework, label printing (auto and manual)

OTC Insights

*The “Rx-to-OTC switch” market is expected to reach $15B in the U.S. by 2015[i], with eight of the current top 20 OTC brands in Europe being the result of product switches[ii]. A recent report has identified $30B worth of potential Rx-to-OTC switches in a wide range of indications, from hypertension and COPD to high cholesterol[iii].

[i] Pharma marketing and sales: When to make an Rx to OTC switch. Eye for Pharma. Jan 24, 2012.

[ii] Maximizing Rx-to-OTC Switch Potential. IMS Health. 2010.

[iii] New Francesco International Report Reveals $30 Billion of Fresh Opportunities for Rx-to-OTC Switch. Feb 10, 2013.

We’re able to provide FDA-approved plastic packaging that is sterile or static-shielding for medical device shipments. We also offer a vast array of equipment specifically designed for the medical packaging category.

Examples of Our Work

Bio true